CN104902879B - 掩味活性粉末药物组合物及其制备方法 - Google Patents

掩味活性粉末药物组合物及其制备方法 Download PDF

Info

Publication number
CN104902879B
CN104902879B CN201380053749.6A CN201380053749A CN104902879B CN 104902879 B CN104902879 B CN 104902879B CN 201380053749 A CN201380053749 A CN 201380053749A CN 104902879 B CN104902879 B CN 104902879B
Authority
CN
China
Prior art keywords
polymer
silica
ibuprofen
coated
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380053749.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN104902879A (zh
Inventor
丹尼尔·多
拉杰什·N·戴夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New Jersey Institute of Technology
Original Assignee
New Jersey Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Jersey Institute of Technology filed Critical New Jersey Institute of Technology
Publication of CN104902879A publication Critical patent/CN104902879A/zh
Application granted granted Critical
Publication of CN104902879B publication Critical patent/CN104902879B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
CN201380053749.6A 2012-10-15 2013-10-09 掩味活性粉末药物组合物及其制备方法 Active CN104902879B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/651,829 US8993041B2 (en) 2012-10-15 2012-10-15 Taste masked active pharmaceutical powder compositions and processes for making them
US13/651,829 2012-10-15
PCT/US2013/064064 WO2014062446A1 (en) 2012-10-15 2013-10-09 Taste masked active pharmaceutical powder compositions and processes for making them

Publications (2)

Publication Number Publication Date
CN104902879A CN104902879A (zh) 2015-09-09
CN104902879B true CN104902879B (zh) 2018-07-17

Family

ID=49447846

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380053749.6A Active CN104902879B (zh) 2012-10-15 2013-10-09 掩味活性粉末药物组合物及其制备方法

Country Status (7)

Country Link
US (1) US8993041B2 (enExample)
EP (1) EP2906204B1 (enExample)
JP (1) JP6166859B2 (enExample)
CN (1) CN104902879B (enExample)
AR (1) AR093012A1 (enExample)
BR (1) BR112015008284B1 (enExample)
WO (1) WO2014062446A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107851B2 (en) * 2012-10-15 2015-08-18 New Jersey Institute Of Technology Solventless mixing process for coating pharmaceutical ingredients
US9801820B2 (en) 2012-11-12 2017-10-31 New Jersey Institute Of Technology Pharmaceutical core-shell composite powder and processes for making the same
CN104587472B (zh) * 2014-12-31 2017-12-15 广东国方医药科技有限公司 一种含纳米SiO2的包衣剂及其制备方法
JP6067154B1 (ja) * 2016-01-25 2017-01-25 株式会社樋口商会 コーティング粒子の製造方法
MX391305B (es) * 2016-03-15 2025-03-21 Acer Therapeutics Inc Composiciones degustables que incluyen fenilbutirato de sodio y usos de las mismas.
US11794161B1 (en) 2018-11-21 2023-10-24 Trucapsol, Llc Reduced permeability microcapsules
JP7750663B2 (ja) * 2021-03-19 2025-10-07 エスエス製薬株式会社 被覆固形医薬製剤
US12302933B2 (en) 2021-06-25 2025-05-20 Trucapsol Llc Flavor delivery system
US12187829B2 (en) 2021-08-12 2025-01-07 Trucapsol Llc Environmentally biodegradable microcapsules
US11878280B2 (en) 2022-04-19 2024-01-23 Trucapsol Llc Microcapsules comprising natural materials
US11904288B1 (en) 2023-02-13 2024-02-20 Trucapsol Llc Environmentally biodegradable microcapsules
US11969491B1 (en) 2023-02-22 2024-04-30 Trucapsol Llc pH triggered release particle

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1373658A (zh) * 1999-07-08 2002-10-09 伊西法姆公司 制备遮味的且活性物质即释的包衣颗粒的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258809A (ja) * 1987-04-16 1988-10-26 Towa Yakuhin Kk 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
EP0524180B1 (en) 1990-04-11 1995-04-26 The Upjohn Company Taste masking of ibuprofen by fluid bed coating
JPH08333240A (ja) * 1995-06-02 1996-12-17 Shin Etsu Chem Co Ltd 粉末またはペレット状ワックスを用いる無溶媒腸溶性コーティング剤で被覆した腸溶性製剤
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
JP2000053563A (ja) * 1998-08-07 2000-02-22 Bayer Yakuhin Ltd 苦味がマスクされた速放性細粒剤
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
GB0010446D0 (en) * 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
US7276249B2 (en) 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
EP1526843A1 (en) * 2002-07-25 2005-05-04 Pharmacia Corporation Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former
US8252370B1 (en) 2005-10-20 2012-08-28 The United States Of America As Represented By The Secretary Of The Army Continuous high-speed coating of finely ground particulates
DE102005062270A1 (de) * 2005-12-24 2007-06-28 Bayer Technology Services Gmbh Geschmacksmaskierung von Pulvern
PT2094382E (pt) * 2006-11-10 2012-07-24 New Jersey Tech Inst Sistemas e métodos de leito fluidizado incluindo fluxo gasoso secundário
EP2201939A1 (en) 2008-12-25 2010-06-30 Zentiva Kimyasal Ürünler Sanayi ve Ticaret A.S. Method for producing coated spiramycin and novel formulations containing the same
RU2567032C2 (ru) * 2009-05-01 2015-10-27 Апталис Фарматек, Инк. Перорально распадающиеся таблеточные композиции, содержащие комбинации неопиоидных и опиоидных анальгетиков

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1373658A (zh) * 1999-07-08 2002-10-09 伊西法姆公司 制备遮味的且活性物质即释的包衣颗粒的方法

Also Published As

Publication number Publication date
BR112015008284B1 (pt) 2022-05-24
US8993041B2 (en) 2015-03-31
JP2015533164A (ja) 2015-11-19
AR093012A1 (es) 2015-05-13
WO2014062446A1 (en) 2014-04-24
CN104902879A (zh) 2015-09-09
EP2906204A1 (en) 2015-08-19
US20140106058A1 (en) 2014-04-17
BR112015008284A2 (pt) 2017-07-04
JP6166859B2 (ja) 2017-07-19
EP2906204B1 (en) 2022-09-28

Similar Documents

Publication Publication Date Title
US8993041B2 (en) Taste masked active pharmaceutical powder compositions and processes for making them
CN104968332B (zh) 药用芯-壳复合粉末及其制备方法
Wang et al. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid–polymer hybrid nanoparticles
Möschwitzer et al. Spray coated pellets as carrier system for mucoadhesive drug nanocrystals
B Patel et al. Review of patents and application of spray drying in pharmaceutical, food and flavor industry
Simovic et al. Dry hybrid lipid− silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs
CN104853751B (zh) 用于包衣药物成分的无溶剂混合方法
Mohylyuk et al. Wurster fluidised bed coating of microparticles: towards scalable production of oral sustained-release liquid medicines for patients with swallowing difficulties
Silva et al. Sustainable strategies for nano-in-micro particle engineering for pulmonary delivery
US20050139144A1 (en) Method for the production and the use of microparticles and nanoparticles by constructive micronisation
Knieke et al. Sub-100 micron fast dissolving nanocomposite drug powders
Bohr et al. Nanoembedded microparticles for stabilization and delivery of drug-loaded nanoparticles
JP7236485B2 (ja) 三流体ノズルを用いた吸入用複合粒子の製造方法
Tomoda et al. Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles
To et al. Fluid bed film coating of fine ibuprofen particles
AU2006331009B2 (en) Masking the taste of powders
JP2000500477A (ja) 即時放出型の薬学的組成物
Kwok et al. Formation of protein nano-matrix particles with controlled surface architecture for respiratory drug delivery
JP5171626B2 (ja) 水難溶性薬物含有球形素顆粒の製造方法
Zahariev et al. Casein Micelles as Nanocarriers for Benzydamine Delivery. Polymers 2021, 13, 4357
HU227115B1 (en) Pellets containing pyridazinone derivative
Patil et al. Spherical crystallization in solubility enhancement
Ichikawa et al. 4.4 Design and Formation of Composite Particles
Meng Anti-solvent precipitation and subsequent film formation of hydrophobic drugs for drug delivery

Legal Events

Date Code Title Description
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant